Vivint Solar Files for IPO

Photo of Chris Lange
By Chris Lange Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Vivint Solar Inc. has filed with the U.S. Securities and Exchange Commission (SEC) for an initial public offering (IPO). No terms have been released for the offering, which will total at $200 million. The company plans on listing in the New York Stock Exchange under the symbol VSLR when it enters the market.

After the completion of this offering, 313 Acquisition, an affiliate of Blackstone Group L.P. (NYSE: BX), will continue to own a majority of the voting power of all outstanding shares of the common stock.

The underwriters for this offering are Goldman Sachs, Bank of America Merrill Lynch, Credit Suisse, Citigroup, Morgan Stanley, Deutsche Bank and Barclays.

The company describes itself and strategy as:

We offer distributed solar energy — electricity generated by a solar energy system installed at customers’ locations — to residential customers based on 20-year contracts at prices below their current utility rates. Our customers pay little to no money upfront, typically realize savings of 15% to 30% relative to utility generated electricity immediately following system interconnection to the power grid and continue to benefit from guaranteed energy prices over the term of their contracts, insulating them against unpredictable increases in utility rates.

Vivint had approximately 850,000 subscribers at the end of June. Its total revenue was $6.17 million for the successor company in 2013. Revenue rose to $10 million in the first half of 2014 from the previous year’s revenue of $1.9 million.

Since Vivint was created in May 2011, it has experienced rapid growth to the point of becoming the second-largest installer of solar energy systems — approximately 8% market share in 2013 — in the U.S. residential market, according to GTM Research. Vivint operates in seven states, including California and New York.

READ ALSO: Calithera Files for IPO to Fund Cancer Tumor Therapy Projects

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618